Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Xindan Wang

The People's Hospital of Guangxi Zhuang Autonomous Region

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

Novel cubic arginine catalysts synergize high-dose radiotherapy for enhanced cervical cancer immunotherapy

Journal of Nanobiotechnology

Preclinical animal study of a novel nanoparticle catalyst combined with radiotherapy showing mechanistic activity and tumor inhibition in a single model system, without human data or direct clinical translation evidence.

PreliminaryZhiqin Deng Haoran Wu Xindan Wang

Reported

Tumor inhibition rateover 90%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support